DiMartino Jorge 4
4 · Kronos Bio, Inc. · Filed Feb 17, 2022
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
DiMartino Jorge
Chief Medical Officer & VP
Transactions
- Award
Common Stock
2022-02-15+60,300→ 177,835 total - Award
Employee Stock Option (Right to Buy)
2022-02-15+90,000→ 90,000 totalExercise: $7.08Exp: 2032-02-14→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.